Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
about
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastasesMethylation signature of lymph node metastases in breast cancer patientsNo evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal CancersEpigenetic therapies - a new direction in clinical medicine.Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
P2860
Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@en
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@nl
type
label
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@en
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@nl
prefLabel
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@en
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@nl
P2093
P1476
Stage III colorectal cancer: m ...... ers and lymph node metastases.
@en
P2093
Angela H Ting
Craig A Messick
James M Church
Matthew F Kalady
P2860
P2888
P304
P356
10.1245/S10434-009-0783-Z
P577
2009-11-03T00:00:00Z